0001209191-20-059450.txt : 20201119 0001209191-20-059450.hdr.sgml : 20201119 20201119170403 ACCESSION NUMBER: 0001209191-20-059450 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201117 FILED AS OF DATE: 20201119 DATE AS OF CHANGE: 20201119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KARBE FRANK CENTRAL INDEX KEY: 0001276700 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37929 FILM NUMBER: 201329492 MAIL ADDRESS: STREET 1: C/O MYOVANT SCIENCES INC. STREET 2: 2000 SIERRA POINT PARKWAY, 9TH FLOOR CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Myovant Sciences Ltd. CENTRAL INDEX KEY: 0001679082 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: CA FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: SUITE 1, 3RD FLOOR STREET 2: 11-12 ST. JAMES SQUARE CITY: LONDON STATE: X0 ZIP: SW1Y 4LB BUSINESS PHONE: 44 207-400-3351 MAIL ADDRESS: STREET 1: SUITE 1, 3RD FLOOR STREET 2: 11-12 ST. JAMES SQUARE CITY: LONDON STATE: X0 ZIP: SW1Y 4LB 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-17 0 0001679082 Myovant Sciences Ltd. MYOV 0001276700 KARBE FRANK C/O MYOVANT SCIENCES INC. 2000 SIERRA POINT PARKWAY, 9TH FLOOR BRISBANE CA 94005 0 1 0 0 Principal Fin'l & Accounting Common Shares 2020-11-17 4 M 0 750 5.11 A 164220 D Common Shares 2020-11-17 4 S 0 750 20.00 D 163470 D Stock Option (Right to Buy) 5.11 2020-11-17 4 M 0 750 0.00 D 2026-09-20 Common Shares 750 197894 D Shares sold pursuant to a 10b5-1 trading plan. Fully vested. /s/ Matthew Lang, Attorney-in-Fact 2020-11-19